NO20090817L - Nye kromen- og tiokromenkarboksaminderivater, fremgangsmater for fremstilling av disse og terapeutiske applikasjoner av dem - Google Patents
Nye kromen- og tiokromenkarboksaminderivater, fremgangsmater for fremstilling av disse og terapeutiske applikasjoner av demInfo
- Publication number
- NO20090817L NO20090817L NO20090817A NO20090817A NO20090817L NO 20090817 L NO20090817 L NO 20090817L NO 20090817 A NO20090817 A NO 20090817A NO 20090817 A NO20090817 A NO 20090817A NO 20090817 L NO20090817 L NO 20090817L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- preparation
- thiochromocarboxamine
- processes
- therapeutic applications
- Prior art date
Links
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052804 chromium Inorganic materials 0.000 title abstract 2
- 239000011651 chromium Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0606682A FR2903986A1 (fr) | 2006-07-21 | 2006-07-21 | Nouveaux derives chromenes ou thiochromenes carboxamides, leur procede de preparation et leurs applications en therapeutique |
| PCT/EP2007/057511 WO2008009741A1 (en) | 2006-07-21 | 2007-07-20 | Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090817L true NO20090817L (no) | 2009-03-18 |
Family
ID=37726847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090817A NO20090817L (no) | 2006-07-21 | 2009-02-20 | Nye kromen- og tiokromenkarboksaminderivater, fremgangsmater for fremstilling av disse og terapeutiske applikasjoner av dem |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20100029682A1 (pt) |
| EP (1) | EP2057138A1 (pt) |
| JP (1) | JP2009544657A (pt) |
| KR (1) | KR20090029848A (pt) |
| CN (1) | CN101490030A (pt) |
| AR (1) | AR062013A1 (pt) |
| AU (1) | AU2007275141A1 (pt) |
| BR (1) | BRPI0714501A2 (pt) |
| CA (1) | CA2659524A1 (pt) |
| CL (1) | CL2007002133A1 (pt) |
| FR (1) | FR2903986A1 (pt) |
| IL (1) | IL196190A0 (pt) |
| MA (1) | MA30630B1 (pt) |
| MX (1) | MX2009000786A (pt) |
| NO (1) | NO20090817L (pt) |
| NZ (1) | NZ574416A (pt) |
| RU (1) | RU2009105697A (pt) |
| TN (1) | TN2009000014A1 (pt) |
| TW (1) | TW200817383A (pt) |
| WO (1) | WO2008009741A1 (pt) |
| ZA (1) | ZA200900777B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2949465B1 (fr) * | 2009-09-01 | 2011-08-12 | Pf Medicament | Derives chromones, leur procede de preparation et leurs applications therapeutiques |
| US8598357B2 (en) * | 2011-03-03 | 2013-12-03 | Hoffmann-La Roche Inc. | Benzodioxole piperidine compounds |
| KR101627841B1 (ko) * | 2015-05-27 | 2016-06-07 | 다이아텍코리아 주식회사 | 싸이오크로멘 타입 화합물 및 그 용도 |
| SI3429993T1 (sl) | 2016-03-14 | 2021-09-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer | Selektivni antagonisti/delni agonisti dopaminskega receptorja D3; postopki izdelave; in uporaba le-teh |
| US11299476B2 (en) | 2016-03-14 | 2022-04-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof |
| JP6767679B2 (ja) * | 2017-05-29 | 2020-10-14 | 京セラドキュメントソリューションズ株式会社 | 印刷システム |
| CN108822065B (zh) * | 2018-05-31 | 2021-06-25 | 四川农业大学 | 一种苯并吡喃类化合物及其制备方法和应用 |
| WO2020055725A1 (en) | 2018-09-11 | 2020-03-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dopamine d3 receptor selective antagonists/partial agonists and uses thereof |
| CN109678878A (zh) * | 2019-02-27 | 2019-04-26 | 陕西科技大学 | 一种苯并噻吩并香豆素类化合物及其合成方法 |
| CN109678879A (zh) * | 2019-02-27 | 2019-04-26 | 陕西科技大学 | 一种苯并噻吩并吡喃酮类化合物及其合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0103987A3 (en) * | 2001-09-28 | 2004-11-29 | Richter Gedeon Vegyeszet | Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates |
| WO2004004729A1 (de) * | 2002-07-04 | 2004-01-15 | Schwarz Pharma Ag | Heteroarencarboxamide zur verwendung als dopamin-d3 liganden zur behandlung von zns-erkrankungen |
| AU2003267201B2 (en) * | 2002-09-14 | 2009-04-23 | The Gov't Of The U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services | Structurally rigid dopamine D3 receptor selective ligands and process for making them |
| US20080275028A1 (en) * | 2004-07-20 | 2008-11-06 | Giovanni Gaviraghi | Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof |
| NZ555491A (en) * | 2005-01-03 | 2010-01-29 | Univ Siena | Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
-
2006
- 2006-07-21 FR FR0606682A patent/FR2903986A1/fr not_active Withdrawn
-
2007
- 2007-07-20 BR BRPI0714501-2A patent/BRPI0714501A2/pt not_active IP Right Cessation
- 2007-07-20 EP EP07787765A patent/EP2057138A1/en not_active Withdrawn
- 2007-07-20 CL CL200702133A patent/CL2007002133A1/es unknown
- 2007-07-20 AU AU2007275141A patent/AU2007275141A1/en not_active Abandoned
- 2007-07-20 US US12/374,088 patent/US20100029682A1/en not_active Abandoned
- 2007-07-20 CN CNA2007800260967A patent/CN101490030A/zh active Pending
- 2007-07-20 KR KR1020097003132A patent/KR20090029848A/ko not_active Withdrawn
- 2007-07-20 NZ NZ574416A patent/NZ574416A/en not_active IP Right Cessation
- 2007-07-20 JP JP2009521238A patent/JP2009544657A/ja not_active Withdrawn
- 2007-07-20 RU RU2009105697/04A patent/RU2009105697A/ru unknown
- 2007-07-20 TW TW096126606A patent/TW200817383A/zh unknown
- 2007-07-20 WO PCT/EP2007/057511 patent/WO2008009741A1/en not_active Ceased
- 2007-07-20 MX MX2009000786A patent/MX2009000786A/es not_active Application Discontinuation
- 2007-07-20 AR ARP070103250A patent/AR062013A1/es not_active Application Discontinuation
- 2007-07-20 CA CA002659524A patent/CA2659524A1/en not_active Abandoned
-
2008
- 2008-12-25 IL IL196190A patent/IL196190A0/en unknown
-
2009
- 2009-01-16 TN TN2009000014A patent/TN2009000014A1/fr unknown
- 2009-02-02 ZA ZA200900777A patent/ZA200900777B/xx unknown
- 2009-02-05 MA MA31619A patent/MA30630B1/fr unknown
- 2009-02-20 NO NO20090817A patent/NO20090817L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200817383A (en) | 2008-04-16 |
| AU2007275141A1 (en) | 2008-01-24 |
| MA30630B1 (fr) | 2009-08-03 |
| US20100029682A1 (en) | 2010-02-04 |
| ZA200900777B (en) | 2010-01-27 |
| CA2659524A1 (en) | 2008-01-24 |
| EP2057138A1 (en) | 2009-05-13 |
| KR20090029848A (ko) | 2009-03-23 |
| NZ574416A (en) | 2011-01-28 |
| AR062013A1 (es) | 2008-08-10 |
| IL196190A0 (en) | 2009-09-22 |
| TN2009000014A1 (en) | 2010-08-19 |
| WO2008009741A1 (en) | 2008-01-24 |
| BRPI0714501A2 (pt) | 2013-04-24 |
| JP2009544657A (ja) | 2009-12-17 |
| RU2009105697A (ru) | 2010-08-27 |
| CN101490030A (zh) | 2009-07-22 |
| FR2903986A1 (fr) | 2008-01-25 |
| MX2009000786A (es) | 2009-01-29 |
| CL2007002133A1 (es) | 2008-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20085288L (no) | Nye karbonylerte (aza)cykloheksaner som dopamin D3 reseptorligander | |
| UA109260C2 (uk) | Хромонові похідні, спосіб їх одержання та їх терапевтичні застосування | |
| NO20090295L (no) | Substituerte heteroarylderivater | |
| WO2009010455A3 (en) | Pyrazole derivatives as modulators of metabotropic glutamate receptors | |
| NO20093009L (no) | Kondensert ring heterocykel kinase modulatorer | |
| WO2012009009A3 (en) | Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors | |
| ATE445624T1 (de) | Verbindungen und zusammensetzungen als ppar- modulatoren | |
| EA200900023A1 (ru) | Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли | |
| NO20085100L (no) | Nye forbindelser | |
| MY149855A (en) | Benzimidazole derivatives and their use for modulating the gaba? receptor complex | |
| MX2009011951A (es) | Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
| NO20084712L (no) | Nye farmasoytiske forbindelser | |
| ATE482209T1 (de) | Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität | |
| MX2009006170A (es) | Compuestos y composiciones como inhibidores de cinasa. | |
| EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| DK2212283T3 (da) | Substituerede N-phenylbipyrrolidincarboxamider og terapeutisk anvendelse deraf | |
| ATE530524T1 (de) | Substituierte sulfonamid-derivate | |
| DK2212282T3 (da) | Substituerede N-phenylbipyrrolidincarboxamider og terapeutisk anvendelse deraf | |
| MX2009011952A (es) | Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr. | |
| TN2009000014A1 (en) | Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same | |
| ATE554076T1 (de) | Sulfoximinsubstituierte chinazolinderivate als immunmodulatoren, ihre herstellung und ihre verwendung als medikamente | |
| DE602007014206D1 (de) | Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität | |
| UA104880C2 (uk) | Заміщені тетрагідропіранспіропіролідинон і тетрагідропіранспіропіперидинон, спосіб їх одержання й застосування в лікувальних цілях | |
| GB0525069D0 (en) | Organic compounds | |
| WO2009071691A3 (de) | Oxindol-derivate und ihre verwendung als medikament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |